Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 9.19% is 19% below its 2-year average of 11.28%, near the low end of its 2-year range (7.72%–12.87%).
As of the fiscal period ended Tuesday, March 31, 2026. 14.73% below its 12-month average of 10.78%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
9.19%
EBITDA MARGIN AVG TTM
10.78%
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-14.73%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$30.72B
EBITDA Margin
16.19%
TTM Avg
16.24%
3Y Avg
16.31%
5Y Avg
17.37%
Market Cap
$28.62B
EBITDA Margin
30.90%
TTM Avg
31.59%
3Y Avg
31.63%
5Y Avg
30.80%
Market Cap
$38.68B
EBITDA Margin
21.04%
TTM Avg
21.29%
3Y Avg
20.90%
5Y Avg
20.09%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $33.22B | 9.19% | 10.78% | N/A | N/A |
| Zoetis Inc. (ZTS)vs › | $32.40B | 43.14% | 42.58% | 42.20% | 41.87% |
| DexCom, Inc. (DXCM)vs › | $31.49B | 24.96% | 22.62% | 21.42% | 19.95% |
| Centene Corp. (CNC)vs › | $30.74B | -3.26% | -0.27% | 1.02% | 1.75% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.72B | 16.19% | 16.24% | 16.31% | 17.37% |
| ResMed Inc. (RMD)vs › | $30.60B | 37.33% | 35.06% | 33.74% | 33.79% |
| Biogen Inc. (BIIB)vs › | $29.99B | 28.67% | 30.68% | 30.30% | 31.44% |
| Mettler-Toledo International Inc. (MTD)vs › | $28.62B | 30.90% | 31.59% | 31.63% | 30.80% |
| IQVIA Holdings Inc. (IQV)vs › | $38.68B | 21.04% | 21.29% | 20.90% | 20.09% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $27.50B | 15.00% | 4.83% | -18.55% | -52.26% |
Gross Margin
24.0%
EBITDA Margin
9.2%
Operating Margin
7.0%
Net Margin
3.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | 9.19% |
| 2025-12-31 | 7.72% |
| 2025-09-30 | 11.62% |
| 2025-06-30 | 12.77% |
| 2025-03-31 | 12.61% |
| 2024-09-30 | 12.87% |
| 2024-06-30 | 12.21% |
